Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection
Main Authors: | D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320361620 |
Similar Items
-
Patients with biochemical recurrence after radical prostatectomy and local recurrence or negative PSMA PET/CT are excellent candidates for salvage radiotherapy to the prostatic fossa
by: H.B. Luiting, et al.
Published: (2020-07-01) -
Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging
by: D. Meijer, et al.
Published: (2020-11-01) -
Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? the DeTeCT trial
by: Y.J.L. Bodar, et al.
Published: (2020-07-01) -
The clinical, radiological, pathological and oncological outcomes of prostate cancer patients undergoing PSMA PET/CT imaging for initial staging; comparing those with PSMA-avid Lesions suspicious for prostate cancer to those who have not
by: A.N. Veerman, et al.
Published: (2020-11-01) -
Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies. The SESAME-study
by: Y.J.L. Bodar, et al.
Published: (2020-11-01)